Thailand FDA, Firms To Fund Equipment, Drugs In Rural Hospitals
This article was originally published in PharmAsia News
Executive Summary
Thailand's FDA is joining with the private sector to increase access to medical equipment and drugs in the isolated parts of the country. A deputy permanent secretary in the Public Health Ministry launched the effort to replace a failed try he had made while serving as head of the FDA. Instead of relying on obtaining budget funds for the push, the government instead is collaborating with the private sector to help rural hospitals buy essential medical equipment. The program also is intended to increase access to medication in at least 15 isolated hospitals. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.